Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIR2.2 Inhibitors

Chemical inhibitors of KIR2.2, a type of potassium channel, operate by obstructing the normal flow of potassium ions through the channel, which is crucial for maintaining the resting membrane potential and the repolarization phase of the action potential in cells. Quinidine, for instance, blocks the voltage-gated potassium channels, thereby directly inhibiting the ion flow that KIR2.2 mediates. Similarly, Amiodarone also serves as a blocker of potassium channels, including KIR2.2, ensuring that the passage of potassium ions is halted and the channel's normal function is disrupted. Sotalol, while recognized as a beta-blocker, doubles as a KIR2.2 antagonist by inhibiting the ion conduction that KIR2.2 facilitates. This in turn affects the channel's role in cardiac action potentials. Another compound, Dofetilide, exhibits selectivity for potassium channel blocking, targeting KIR2.2 and impeding potassium ion movement out of the cell, which is an essential part of the channel's activity.

In addition to the aforementioned inhibitors, Ibutalide and Azimilide are noted for their inhibitory effects on KIR2.2. Ibutalide achieves this by blocking the flow of potassium ions through the channel, while Azimilide is known to inhibit both inward rectifier and delayed rectifier potassium channels, including KIR2.2, thereby preventing the typical K+ ion flow. Disopyramide, although primarily affecting Na+ channels, can reduce potassium ion conductance through KIR2.2, influencing the channel's electrophysiological role. Flecaïnide and Propafenone, which are mainly sodium channel blockers, also demonstrate the capacity to inhibit KIR2.2 by decreasing potassium ion permeability. Tedisamil and Sematilide, both potassium channel blockers, inhibit multiple types of potassium channels, including KIR2.2, by directly blocking the flow of K+ ions. Lastly, Nifekalant, a potassium channel blocker, specifically inhibits KIR2.2 by precluding the movement of potassium ions, which is integral to the electrophysiological functions the channel performs.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Quinidine

56-54-2sc-212614
10 g
$104.00
3
(1)

Quinidine is known to block voltage-gated potassium channels, which inhibits the flow of K+ ions. Since KIR2.2 is a potassium channel, quinidine can inhibit its function by obstructing the ion flow through the channel, thereby inhibiting the electrical signaling that depends on KIR2.2 activity.

Amiodarone

1951-25-3sc-480089
5 g
$318.00
(1)

Amiodarone has multiple cardiac effects, one of which includes the inhibition of potassium channels. By blocking the potassium ion passage that KIR2.2 mediates, amiodarone inhibits the repolarization phase of the cardiac action potential, which directly inhibits the functional activity of KIR2.2 channels.

Sotalol hydrochloride

959-24-0sc-203699
sc-203699A
10 mg
50 mg
$68.00
$251.00
3
(1)

Sotalol acts as a beta-blocker but also possesses the ability to inhibit potassium channels. It blocks the ion conduction of KIR2.2, thus inhibiting the channel's ability to contribute to the maintenance of the cell's resting membrane potential and repolarization of the action potential.

Propafenone Hydrochloride

34183-22-7sc-204863
sc-204863A
sc-204863B
sc-204863C
1 g
5 g
25 g
100 g
$21.00
$66.00
$198.00
$501.00
(1)

Propafenone has a mild inhibitory effect on potassium channels, in addition to its primary role as a sodium channel blocker. It inhibits KIR2.2 by decreasing potassium ion permeability and can directly inhibit the cardiac action potentials that KIR2.2 helps to regulate.